Highly suspected valsartan-induced chronic erythema nodosum migrans in a patient with hypertension: a case report

J Int Med Res. 2022 Feb;50(2):3000605221079553. doi: 10.1177/03000605221079553.

Abstract

Erythema nodosum migrans (ENM) is usually considered as a rare clinical variant of erythema nodosum and is characterized by unilateral, migratory, relatively painless, nodular lesions. ENM cases are rarely reported and most cases are idiopathic. Therefore, the appropriate treatment modality of ENM is unknown. We report a 72-year-old woman with highly suspected valsartan-induced ENM. She experienced painful, infiltrated, centrifugally spreading, slightly morpheaform, erythematous plaques on the flexor side of her left leg. Her symptoms were relieved after discontinuation of valsartan and temporary administration of oral prednisone once daily (20 mg for the first 7 days and 10 mg for the next 7 days).

Keywords: Valsartan; erythema nodosum migrans; hypertension; lesion; nifedipine; plaque.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Chronic Disease
  • Erythema Nodosum* / chemically induced
  • Erythema Nodosum* / diagnosis
  • Erythema Nodosum* / drug therapy
  • Female
  • Humans
  • Hypertension* / complications
  • Valsartan / therapeutic use

Substances

  • Valsartan